Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

68.30
Delayed Data
As of Apr 28
 +0.04 / +0.06%
Today’s Change
32.40
Today|||52-Week Range
75.36
+29.43%
Year-to-Date

Today’s Trading

Previous close68.26
Today’s open68.61
Day’s range67.44 - 71.32
Volume1,112,773
Average volume (3 months)926,610
Market cap$9.7B
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-7.53%
Earnings growth (this year)-79.07%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+24.15%
P/E ratioNM
Price/Sales17.76
Price/Book15.31

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-2.73-1.69%
PRGOPerrigo Company PLC-0.07-0.09%
ALKSAlkermes Plc+1.95+3.46%
TSROTESARO Inc+0.98+0.67%
Data as of 4:14pm ET, 04/28/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$418.1M
Annual profit (last year)-$140.1M
Net profit margin-33.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts